Back to User profile » Prof. Dr. Jae-Wook Ko
Papers published by Prof. Dr. Jae-Wook Ko:
No pharmacokinetic interactions between candesartan and amlodipine following multiple oral administrations in healthy subjects
Kim JR, Kim S, Huh W, Ko JW
Drug Design, Development and Therapy 2018, 12:2475-2483
Published Date: 10 August 2018
Association of genetic variations with pharmacokinetics and lipid-lowering response to atorvastatin in healthy Korean subjects
Woo HI, Kim SR, Huh W, Ko JW, Lee SY
Drug Design, Development and Therapy 2017, 11:1135-1146
Published Date: 4 April 2017
A proposal for an individualized pharmacogenetic-guided isoniazid dosage regimen for patients with tuberculosis
Jung JA, Kim TE, Lee H, Jeong BH, Park HY, Jeon K, Kwon OJ, Ko JW, Choi R, Woo HI, Koh WJ, Lee SY
Drug Design, Development and Therapy 2015, 9:5433-5438
Published Date: 30 September 2015
Effects of amoxicillin/clavulanic acid on the pharmacokinetics of valproic acid
Lee SY, Huh W, Jung JA, Yoo HM, Ko JW, Kim JR
Drug Design, Development and Therapy 2015, 9:4559-4563
Published Date: 10 August 2015
Bioequivalence evaluation of two amlodipine salts, besylate and orotate, each in a fixed-dose combination with olmesartan in healthy subjects
Lee SY, Kim JR, Jung JA, Huh W, Bahng MY, Ko JW
Drug Design, Development and Therapy 2015, 9:2811-2817
Published Date: 2 June 2015
Lack of the effect of lobeglitazone, a peroxisome proliferator-activated receptor-γ agonist, on the pharmacokinetics and pharmacodynamics of warfarin
Jung JA, Lee SY, Kim TE, Kim JR, Kim C, Huh W, Ko JW
Drug Design, Development and Therapy 2015, 9:737-743
Published Date: 2 March 2015
A pharmacokinetic and pharmacodynamic drug interaction between rosuvastatin and valsartan in healthy subjects
Jung JA, Lee SY, Kim JR, Ko JW, Jang SB, Nam SY, Huh W
Drug Design, Development and Therapy 2015, 9:745-752
Published Date: 2 March 2015